Results 331 to 340 of about 83,254 (357)
Some of the next articles are maybe not open access.

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors   +2 more
exaly  

What are Janus kinase (JAK) inhibitors?

Pediatric Dermatology
JAK inhibitors are medications that can lower inflammation in the body. Some inflammation can help the body to fight infections or injuries. But too much inflammation is also the cause of certain skin problems. JAK inhibitors can help by lowering inflammation to improve skin diseases.
openaire   +2 more sources

[Janus kinase inhibitors for skin disorders].

Dermatologie (Heidelberg, Germany)
Immune factors such as interferon‑ɣ and interleukin 4 belong to the group of cytokines that are dependent on type I/II receptors for their signal transmission. Upon activation, these receptors transmit their signal to the cell nucleus and, thus, modulate gene transcription via a signaling cascade consisting of Janus kinases (JAK).
Farzan, Solimani, Kamran, Ghoreschi
openaire   +1 more source

Questioning the Janus Kinase (JAK) Inhibitors!

C59. POTRERO HILL: CASE REPORTS IN PULMONARY HYPERTENSION, 2022
H. Hussain, S. Faryad, D. Taneja
openaire   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Phosphodiesterase-4 and Janus Kinase Inhibitors

2021
Gillian Weston, Bruce Strober
openaire   +1 more source

Home - About - Disclaimer - Privacy